Saturday, February 27, 2016
Wonder Drug, Wonder Woman
cost for local woman out of reach for most MS patients
the past few years, Kimberlee Moran was tired and experiencing
painful muscle spasms. The Abbotsford resident attributed the
symptoms to stress – until she woke up one morning with numbness in
her hand that lingered for days. Concerned, Kim visited her doctor
who told her she likely had carpal tunnel syndrome and advised her
to wear a brace.
A few months
later, Kim was experiencing what felt like “an electric shock” down
her side whenever she would tilt her head forward, in addition to
tingling in her legs and vision problems. After conducting x-rays
and an MRI, Kim was officially diagnosed with relapsing remitting
multiple sclerosis (RRMS) on November 10, 2014.
“At the time, I was loving life. I had just turned 30, was happily
married and was training to run a half marathon. Professionally, I
had just been promoted and was traveling a lot for speaking
engagements. I felt like I had a handle on things,” Kim says. “But
as soon as I saw the MRI results, I knew it was MS. The diagnosis
happened so quickly that I barely had time to wrap my head around
After researching her treatment options, Kim chose a new and
different type of MS treatment called LEMTRADA™(alemtuzumab).
Requiring only two treatment courses one year apart, LEMTRADA is
first administered by intravenous infusion on five consecutive days
and then on three consecutive days, 12 months later.
requiring monitoring at regular intervals between treatment courses
and for 48 months following the final infusion, clinical studies to
date have shown that 80 per cent of RRMS patients who received two
treatment courses of LEMTRADA required no further therapy.
LEMTRADA because of the hope it instilled,” says Kim. “So when I
found out my private insurance wouldn’t cover the treatment for me,
I was devastated. I felt like that hope had been snatched away.”
Fortunately, a friend of a friend who was acquainted with the
progressive nature of MS offered to pay for Kim’s first round of
treatment. Meanwhile, another friend offered to help her with any
I left my last appointment, I finally felt like it’s going to be
possible for me to live a normal life and that I won’t have to give
up some of the things I thought I would,” says Kim. “Access to a
treatment that could stop the progression of the disease is a game
changer. With it, there are so many possibilities that can come to
people with MS. LEMTRADA changed everything for me.”
Finishing her second - and hopefully last - round of treatment on
February 23, 2015, Kim is planning on running a half marathon in
Both Kim and her neurologist firmly believe she made the right
treatment decision for her.
You can also
read more about her MS journey on her personal blog,
MS in Canada
With 100,000 Canadians living with MS and three people newly
diagnosed every day, Canada has one of the highest prevalence rates
in the world. As most people are diagnosed with relapsing MS in
their twenties and thirties, MS is the most common neurological
disease affecting young adults in Canada.
The Valley Voice
News| All Rights